We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Unboosted Atazanavir as Initial ART Therapy in China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01459575
Recruitment Status : Completed
First Posted : October 25, 2011
Last Update Posted : October 25, 2011
BMS company
Information provided by (Responsible Party):
NCAIDS, National Center for AIDS/STD Control and Prevention, China CDC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2005
  Study Completion Date : December 2006